These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11481240)

  • 1. Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice.
    Choi SH; Park CH; Koo JW; Seo JH; Kim HS; Jeong SJ; Lee JH; Kim SS; Suh YH
    FASEB J; 2001 Aug; 15(10):1816-8. PubMed ID: 11481240
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.
    Deibel SH; Weishaupt N; Regis AM; Hong NS; Keeley RJ; Balog RJ; Bye CM; Himmler SM; Whitehead SN; McDonald RJ
    Brain Res; 2016 Sep; 1646():12-24. PubMed ID: 27208489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
    J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H; Yang H; Xie Z; Wang P; Bi J
    Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.
    Wang D; Noda Y; Zhou Y; Mouri A; Mizoguchi H; Nitta A; Chen W; Nabeshima T
    Neuropsychopharmacology; 2007 Jun; 32(6):1261-71. PubMed ID: 17133263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New approach for the studies on Alzheimer's disease: a beta 1-42 and acetylcholine].
    Hoshi M
    Seikagaku; 1997 Mar; 69(3):181-7. PubMed ID: 9125900
    [No Abstract]   [Full Text] [Related]  

  • 8. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
    Long Z; Zeng Q; Wang K; Sharma A; He G
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of electroacupuncture on the behavior and the expression of amyloid beta-protein, amyloid precursor protein and ChAT in APP 695 V 717 I transgenic mice].
    Xue WG; Zhang Z; Bai LM; Xu H; Wu HX
    Zhen Ci Yan Jiu; 2009 Jun; 34(3):152-8. PubMed ID: 19761106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.
    Hoshi M; Takashima A; Murayama M; Yasutake K; Yoshida N; Ishiguro K; Hoshino T; Imahori K
    J Biol Chem; 1997 Jan; 272(4):2038-41. PubMed ID: 8999897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexapeptides HLDF-6 and PEDF-6 restore memory in rats after chronic intracerebroventricular treatment with beta-amyloid peptide Abeta(25-35).
    Storozheva ZI; Proshin AT; Zhokhov SS; Sherstnev VV; Rodionov IL; Lipkin VM; Kostanyan IA
    Bull Exp Biol Med; 2006 Mar; 141(3):319-22. PubMed ID: 17073149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
    Arendash GW; Gordon MN; Diamond DM; Austin LA; Hatcher JM; Jantzen P; DiCarlo G; Wilcock D; Morgan D
    DNA Cell Biol; 2001 Nov; 20(11):737-44. PubMed ID: 11788052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.
    Canas PM; Simões AP; Rodrigues RJ; Cunha RA
    Neuropharmacology; 2014 Jan; 76 Pt A():51-6. PubMed ID: 24029236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
    Choi YY; Maeda T; Fujii H; Yokozawa T; Kim HY; Cho EJ; Shibamoto T
    Nutr Res; 2014 Jul; 34(7):595-603. PubMed ID: 25150118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
    J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.